reference/352785

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/352785

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study
endingPage	698
issn	1042-8194 1029-2403
issueIdentifier	4
pageRange	691-698
publicationName	Leukemia & Lymphoma
startingPage	691
bibliographicCitation	Fermé C, Brice P, Michallet AS, Lederlin P, Diviné M, Casasnovas O, Devidas A, Anglaret B, Cazals-Hatem D, Mounier N; Groupe d'Etudes des Lymphomes de L'adulte. A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Leuk Lymphoma. 2007 Apr;48(4):691–8. doi: 10.1080/10428190601175369. PMID: 17454626.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca049552abd06f2a9d9f1803cc895b87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19b3db8f0808db93dbf16603d8217253 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ea98a5dc36acafe801ba1f2836391c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fad039eb4e37f654db03073a8f24093 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0707-426X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5474791e8ff72d6903fe36c02b3c279b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68fcb766857ad686b833c586fe27ab8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a23a37868dfdb7c7190c850bf9168eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a1e777e5d8b857a2012bd93c8b8f5a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fd23b090c028ec647b414be66a1ead4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdc674b119120883e9687bf9adf36f54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d865e1342958a0d76ae6f356ceb6092d
date	2007-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17454626 https://doi.org/10.1080/10428190601175369
isPartOf	https://portal.issn.org/resource/ISSN/1029-2403 https://portal.issn.org/resource/ISSN/1042-8194 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2306
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: Results of a phase II study of the Groupe d'Études des Lymphomes de l'Adulte (GELA)
discusses	http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0001348
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006689Q000188 http://id.nlm.nih.gov/mesh/D000903Q000008 http://id.nlm.nih.gov/mesh/D000903Q000627 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D004317Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012307
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44417235 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155903698 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84068 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241903 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460769 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456190 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133126830 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6710780 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823887 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129009934 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8035 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11104792 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360373 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135935854

Total number of triples: 74.